同仁堂品牌始創(chuàng)于1669年（清康熙八年）。自1723年（清雍正元年）為清宮供御藥，歷經(jīng)八代皇帝長達188年。

Tong Ren Tang Founded in 1669． It served eight Qing emperors for 188 years since it was designated to provide traditional Chinese medicine to the imperial family in 1723。

1949年新中國成立，使飽經(jīng)滄桑的同仁堂獲得了新生。1992年中國北京同仁堂集團公司組建并于2001年改制為國有獨資公司，現(xiàn)代企業(yè)制度在同仁堂集團逐步建立完善。

The founding of the People’s Republic of China in 1949 gave a new life to weather－beaten TRT．In 1992， Beijing TRT Group was established，and became a wholly state－owned company in 2001． It has gradually established a modern corporate system．

1997年旗下同仁堂股份在上海上交所上市，2000年同仁堂科技在香港聯(lián)交所上市，2013年同仁堂國藥在香港聯(lián)交所上市，同仁堂集團整體實力躍上了新臺階。

In 1997， the subsidiary Beijing Tong Ren Tang Co．， Ltd． was listed in Shanghai Stock Exchange，while Beijing Tong Ren TangTechnology Development Co．， Ltd． were listed in Hong Kong Stock Exchange in 2000．Beijing Tong Ren Tang Chinese Medicine Co．， Ltd．were listed in Hong Kong Stock Exchangein2013， These listings strengthened the overall competitiveness of Beijing TRT Group．

2019年全面落實黨中央關(guān)于發(fā)展中醫(yī)藥事業(yè)的決策部署，著眼于“兩個一百年”奮斗目標，謀劃同仁堂集團新時代發(fā)展的戰(zhàn)略思路，聘請第三方專業(yè)公司開展戰(zhàn)略咨詢，開啟了邁向高質(zhì)量發(fā)展的新征程。

In 2019， answering the Party’s call to develop TCM， the group invited the third－party company （focus on＂two centenary goals＂）to provide strategic consultancy services and map out the development strategy in the new era， taking the group onto a journey of high－quality growth．